Definitive Healthcare (NASDAQ:DH) Now Covered by Analysts at Stephens

Analysts at Stephens initiated coverage on shares of Definitive Healthcare (NASDAQ:DH) in a research note issued to investors on Friday, Marketbeat reports. The brokerage set an “equal weight” rating and a $5.00 price target on the stock. Stephens’ target price suggests a potential upside of 19.62% from the stock’s previous close.

Other research analysts have also issued reports about the stock. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th. BTIG Research initiated coverage on Definitive Healthcare in a report on Tuesday, September 17th. They issued a “buy” rating and a $7.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $5.72.

Definitive Healthcare Trading Up 1.0 %

NASDAQ DH opened at $4.18 on Friday. The firm has a market capitalization of $482.89 million, a PE ratio of -1.35, a price-to-earnings-growth ratio of 3.29 and a beta of 1.40. Definitive Healthcare has a one year low of $3.19 and a one year high of $10.62. The company has a 50-day simple moving average of $4.41 and a 200-day simple moving average of $4.68. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49.

Insider Buying and Selling

In other news, insider William Moschella sold 45,000 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the transaction, the insider now owns 433,830 shares in the company, valued at $2,039,001. This represents a 9.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 14.84% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Millennium Management LLC acquired a new position in Definitive Healthcare during the second quarter worth $9,283,000. Massachusetts Financial Services Co. MA raised its stake in shares of Definitive Healthcare by 36.8% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after acquiring an additional 1,626,813 shares in the last quarter. 272 Capital LP acquired a new stake in Definitive Healthcare in the 2nd quarter worth approximately $3,480,000. State Street Corp boosted its position in Definitive Healthcare by 29.4% during the third quarter. State Street Corp now owns 1,399,729 shares of the company’s stock worth $6,257,000 after purchasing an additional 317,952 shares during the period. Finally, Marshall Wace LLP acquired a new position in Definitive Healthcare during the second quarter valued at approximately $1,535,000. 98.67% of the stock is owned by institutional investors and hedge funds.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.